Exact Mass: 318.129

Exact Mass Matches: 318.129

Found 113 metabolites which its exact mass value is equals to given mass value 318.129, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Histidyltyrosine

(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H18N4O4 (318.1328)


Histidyltyrosine is a dipeptide composed of histidine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Asparaginyl-Tryptophan

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-(1H-indol-3-yl)propanoate

C15H18N4O4 (318.1328)


Asparaginyl-Tryptophan is a dipeptide composed of asparagine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tyrosyl-Histidine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(1H-imidazol-5-yl)propanoate

C15H18N4O4 (318.1328)


Tyrosyl-Histidine is a dipeptide composed of tyrosine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tryptophyl-Asparagine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoate

C15H18N4O4 (318.1328)


Tryptophyl-Asparagine is a dipeptide composed of tryptophan and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

fluvoxamino acid

(5E)-5-[(2-aminoethoxy)imino]-5-[4-(trifluoromethyl)phenyl]pentanoic acid

C14H17F3N2O3 (318.1191)


fluvoxamino acid is a metabolite of fluvoxamine. Fluvoxamine (brand name Luvox) is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD). Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder. (Wikipedia)

   

Nile red

8-(diethylamino)-12H-10-oxa-5-azatetraphen-12-one

C20H18N2O2 (318.1368)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   
   

Coumanolignan

Coumanolignan

C21H18O3 (318.1256)


   
   

Acetyl triethyl citrate

Acetyl triethyl citrate

C14H22O8 (318.1315)


   
   
   

SCHEMBL14514178

SCHEMBL14514178

C14H22O8 (318.1315)


   

2-O-??-D-Glucopyranoside-4-Hydroxy-4-(2-hdyroxyethyl)-2-cyclohexen-1-one

2-O-??-D-Glucopyranoside-4-Hydroxy-4-(2-hdyroxyethyl)-2-cyclohexen-1-one

C14H22O8 (318.1315)


   

(1aS,3R,4R,4aR,6S,7R,8aS)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-octahydro-1aH-naphtho[1-b]oxirene-4-carboxylic acid

(1aS,3R,4R,4aR,6S,7R,8aS)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-octahydro-1aH-naphtho[1-b]oxirene-4-carboxylic acid

C15H23ClO5 (318.1234)


   
   
   

9-(2-Thienyl)-non-6-en-8-in-4-ol-3-on-isovalerat

9-(2-Thienyl)-non-6-en-8-in-4-ol-3-on-isovalerat

C18H22O3S (318.129)


   

9-(2-Thienyl)-non-6-en-8-in-5-ol-3-on-isovalerat

9-(2-Thienyl)-non-6-en-8-in-5-ol-3-on-isovalerat

C18H22O3S (318.129)


   

Gly-Trp-Gly

H-Gly-Trp-Gly-OH

C15H18N4O4 (318.1328)


   
   

8-4-Aminobiphenyl-guanine

8-4-Aminobiphenyl-guanine

C17H14N6O1 (318.1229)


   

PD-160725 isethionate salt

PD-160725 2-hydroxyethanesulfonic acid salt

C15H18N4O4 (318.1328)


   
   
   
   
   
   
   
   
   

Asn-Trp

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-carbamoylpropanoic acid

C15H18N4O4 (318.1328)


   

His-tyr

2-[2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-imidazol-5-yl)propanoic acid

C15H18N4O4 (318.1328)


A dipeptide formed from L-histidine and L-tyrosine residues.

   

TRP-Asn

2-(2-amino-3-carbamoylpropanamido)-3-(1H-indol-3-yl)propanoic acid

C15H18N4O4 (318.1328)


   

Tyr-his

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H18N4O4 (318.1328)


A dipeptide formed from L-tyrosine and L-histidine residues.

   

2-benzyl-1,2,3,4-tetrahydro-benzo[b][1,6]naphthyridine-10-carboxylic acid

2-benzyl-1,2,3,4-tetrahydro-benzo[b][1,6]naphthyridine-10-carboxylic acid

C20H18N2O2 (318.1368)


   

1-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]-2-methylindole-3-carbaldehyde

1-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]-2-methylindole-3-carbaldehyde

C20H18N2O2 (318.1368)


   

Tritylthiourea

Tritylthiourea

C20H18N2S (318.1191)


   

3,5-Dibenzyloxybenzaldehyde

3,5-Dibenzyloxybenzaldehyde

C21H18O3 (318.1256)


   

2,5-Bis(benzyloxy)benzenecarbaldehyde

2,5-Bis(benzyloxy)benzenecarbaldehyde

C21H18O3 (318.1256)


   

1-benzyl-3-(biphenyl-4-yl)thiourea

1-benzyl-3-(biphenyl-4-yl)thiourea

C20H18N2S (318.1191)


   

10-Undecenyl 2-bromoisobutyrate

10-Undecenyl 2-bromoisobutyrate

C15H27BrO2 (318.1194)


   

N-(6-NITRO-2-OXO-2H-CHROMEN-3-YL)HEPTANAMIDE

N-(6-NITRO-2-OXO-2H-CHROMEN-3-YL)HEPTANAMIDE

C16H18N2O5 (318.1216)


   

methyl 1-(2,2-dimethoxyethyl)-6-oxo-2-phenylpyrimidine-5-carboxylate

methyl 1-(2,2-dimethoxyethyl)-6-oxo-2-phenylpyrimidine-5-carboxylate

C16H18N2O5 (318.1216)


   
   

DIPIVALOYL-L-TARTARIC ACID

DIPIVALOYL-L-TARTARIC ACID

C14H22O8 (318.1315)


   
   

(S)-5-AMINO-2-(BENZYLOXYCARBONYLAMINO)PENTANOIC ACID

(S)-5-AMINO-2-(BENZYLOXYCARBONYLAMINO)PENTANOIC ACID

C16H18N2O5 (318.1216)


   

2,3-bis(phenylmethoxy)benzaldehyde

2,3-bis(phenylmethoxy)benzaldehyde

C21H18O3 (318.1256)


   

METHYL 4-(BENZYLOXY)-[1,1-BIPHENYL]-2-CARBOXYLATE

METHYL 4-(BENZYLOXY)-[1,1-BIPHENYL]-2-CARBOXYLATE

C21H18O3 (318.1256)


   

4-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)butanoic acid

4-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)butanoic acid

C16H18N2O5 (318.1216)


   

N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine

N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine

C17H14N6O (318.1229)


   

3,4-dibenzyloxybenzaldehyde

3,4-dibenzyloxybenzaldehyde

C21H18O3 (318.1256)


   

3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE

3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE

C21H18O3 (318.1256)


   

METHYL 6-N-BOC-AMINO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE

METHYL 6-N-BOC-AMINO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE

C16H18N2O5 (318.1216)


   

4-(1-adamantyl)-2,6-dinitrophenol

4-(1-adamantyl)-2,6-dinitrophenol

C16H18N2O5 (318.1216)


   

tetraethyl 1,1,2,2-ethanetetracarboxylate

tetraethyl 1,1,2,2-ethanetetracarboxylate

C14H22O8 (318.1315)


   

Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester

Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester

C21H18O3 (318.1256)


   

(2S,5R)-6-(benzyloxy)-N-formyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carbohydrazide

(2S,5R)-6-(benzyloxy)-N-formyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carbohydrazide

C15H18N4O4 (318.1328)


   

(-)-Dipivaloyl-L-tartaric Acid

(-)-Dipivaloyl-L-tartaric Acid

C14H22O8 (318.1315)


   

11-Bromoundecyl methacrylate

11-Bromoundecyl methacrylate

C15H27BrO2 (318.1194)


   

4-METHYL-N-(4-NITROPHENYL)-N-(P-TOLYL)ANILINE

4-METHYL-N-(4-NITROPHENYL)-N-(P-TOLYL)ANILINE

C20H18N2O2 (318.1368)


   

(6-Butyl-5-decen-5-yl)-λ2-stannane

(6-Butyl-5-decen-5-yl)-λ2-stannane

C14H30Sn (318.1369)


   

1-(TERT-BUTOXYCARBONYL)-2-(4-CYANOPHENYL)INDOLE

1-(TERT-BUTOXYCARBONYL)-2-(4-CYANOPHENYL)INDOLE

C20H18N2O2 (318.1368)


   

(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid

(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid

C21H18O3 (318.1256)


LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties[1].

   

Quinelorane hydrochloride

Quinelorane hydrochloride

C14H24Cl2N4 (318.1378)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   
   

H-Gly-Gly-Trp-OH

H-Gly-Gly-Trp-OH

C15H18N4O4 (318.1328)


   

H-Trp-gly-gly-OH

2-[[2-[[2-amino-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]acetic acid

C15H18N4O4 (318.1328)


   

L-Asparaginyl-L-tryptophan

L-Asparaginyl-L-tryptophan

C15H18N4O4 (318.1328)


   

3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester

3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester

C21H18O3 (318.1256)


   

2,4-Bis(benzyloxy)benzaldehyde

2,4-Bis(benzyloxy)benzaldehyde

C21H18O3 (318.1256)


   

2-(4-Hydroxy-5-phenyl-1H-pyrazol-3-YL)-1H-benzoimidazole-5-carboxamidine

2-(4-Hydroxy-5-phenyl-1H-pyrazol-3-YL)-1H-benzoimidazole-5-carboxamidine

C17H14N6O (318.1229)


   

2-Acetamido-3-[(4-hydroxy-1-oxononan-3-yl)sulfanyl]propanoate

2-Acetamido-3-[(4-hydroxy-1-oxononan-3-yl)sulfanyl]propanoate

C14H24NO5S- (318.1375)


   

N-methyl-N-[4-[(2-oxo-1-naphthalenylidene)methylamino]phenyl]acetamide

N-methyl-N-[4-[(2-oxo-1-naphthalenylidene)methylamino]phenyl]acetamide

C20H18N2O2 (318.1368)


   

5-[(3,4-Dimethoxyphenyl)methyl]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

5-[(3,4-Dimethoxyphenyl)methyl]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

C16H18N2O5 (318.1216)


   

[5-(2,5-Dimethoxyphenyl)-3-isoxazolyl]-(4-morpholinyl)methanone

[5-(2,5-Dimethoxyphenyl)-3-isoxazolyl]-(4-morpholinyl)methanone

C16H18N2O5 (318.1216)


   

H-Gly-Trp-Gly-OH

H-Gly-Trp-Gly-OH

C15H18N4O4 (318.1328)


   

Ethyl 4-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carboxylate

Ethyl 4-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carboxylate

C13H17F3N4O2 (318.1304)


   

4-methyl-N-[(1-naphthylacetyl)oxy]benzenecarboximidamide

4-methyl-N-[(1-naphthylacetyl)oxy]benzenecarboximidamide

C20H18N2O2 (318.1368)


   

(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

C20H18N2O2 (318.1368)


   

(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]azetidine-2-carbonitrile

(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]azetidine-2-carbonitrile

C20H18N2O2 (318.1368)


   

(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

C20H18N2O2 (318.1368)


   

(3Z)-2-(4-methoxybenzyl)-3-(4-methoxybenzylidene)butanedinitrile

(3Z)-2-(4-methoxybenzyl)-3-(4-methoxybenzylidene)butanedinitrile

C20H18N2O2 (318.1368)


   

N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)

N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)

C18H21ClNO2+ (318.1261)


   

gamma-D-glutamyl-meso-diaminoheptanedioate

gamma-D-glutamyl-meso-diaminoheptanedioate

C12H20N3O7- (318.1301)


   

3-(4-Hydroxyphenyl)-9-methyl-5,9-diaza-14-azoniatetracyclo[6.6.1.02,6.011,15]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

3-(4-Hydroxyphenyl)-9-methyl-5,9-diaza-14-azoniatetracyclo[6.6.1.02,6.011,15]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

C19H16N3O2+ (318.1242)


   

Bis(2-ethoxycarbonylethyl) succinate

Bis(2-ethoxycarbonylethyl) succinate

C14H22O8 (318.1315)


   

Triethyl 2-carboxymethyl-1,2,3-propane-tricarboxylate

Triethyl 2-carboxymethyl-1,2,3-propane-tricarboxylate

C14H22O8 (318.1315)


   
   

Tryptophylasparagine

Tryptophylasparagine

C15H18N4O4 (318.1328)


   

NK372135A

NK372135A

C20H18N2O2 (318.1368)


A dinitrile that is butanedinitrile substituted by 4-methoxybenzyl and 4-methoxybenzylidene groups at positions 2 and 3 respectively. Isolated from the culture broth of the fungus Neosartorya fischeri, it exhibits antifungal activity.

   
   
   

SLMP53-1

SLMP53-1

C20H18N2O2 (318.1368)


SLMP53-1 is a wild-type and mutant p53 reactivator with promising antitumor activity. SLMP53-1 mediates the reprograming of glucose metabolism in cancer cells. SLMP53-1 depletes angiogenesis, decreasing endothelial cell tube formation and vascular endothelial growth factor (VEGF) expression levels[1][2].

   

(2r,3r)-3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate

(2r,3r)-3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate

C14H22O8 (318.1315)


   

(6r)-6-[(2s)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl]-5,6-dihydropyran-2-one

(6r)-6-[(2s)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl]-5,6-dihydropyran-2-one

C14H22O8 (318.1315)


   

5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

C15H23ClO5 (318.1234)


   

3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl 4,5-dihydroxyocta-2,6-dienoate

3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl 4,5-dihydroxyocta-2,6-dienoate

C14H22O8 (318.1315)


   

(4r)-4-hydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

(4r)-4-hydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

C14H22O8 (318.1315)


   

7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

C18H22O3S (318.129)


   

7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

C15H23ClO5 (318.1234)


   

8-[(4-hydroxyphenyl)methyl]-9,10-dihydrophenanthrene-2,5-diol

8-[(4-hydroxyphenyl)methyl]-9,10-dihydrophenanthrene-2,5-diol

C21H18O3 (318.1256)


   

(3e,5r)-7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

(3e,5r)-7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate

C18H22O3S (318.129)


   

(4s,6e)-3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

(4s,6e)-3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

C18H22O3S (318.129)


   

(1as,3r,4r,4ar,6s,7r,8as)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

(1as,3r,4r,4ar,6s,7r,8as)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

C15H23ClO5 (318.1234)


   

4-hydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

4-hydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one

C14H22O8 (318.1315)


   

8-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-6-(prop-2-en-1-yl)chromen-2-one

8-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-6-(prop-2-en-1-yl)chromen-2-one

C21H18O3 (318.1256)


   

2,2-bis(1h-indol-3-yl)ethyl acetate

2,2-bis(1h-indol-3-yl)ethyl acetate

C20H18N2O2 (318.1368)


   

3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate

C18H22O3S (318.129)


   

(5r,6r)-5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[(2s,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

(5r,6r)-5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[(2s,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one

C15H23ClO5 (318.1234)